Literature DB >> 27490999

Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis.

Xiao-Yuan Mao1, Qiu-Qi Li2, Yuan-Feng Gao2, Hong-Hao Zhou2, Zhao-Qian Liu3, Wei-Lin Jin4.   

Abstract

Metastasis is a common phenomenon in the progression and dissemination of cancer. It is estimated that metastasis accounts for 90% cancer-related mortality. Although the formation of tumor metastasis is relatively well understood, the underlying molecular mechanisms responsible for the emergence of aggressive cancer phenotype are still elusive. Figuring out the mechanisms by which cancer cells evade from the tumor is beneficial for obtaining novel and effectively therapeutic approaches. Primary tumors are composed of various subpopulations of cells with heterogeneous metastatic characteristics and the occurrence of metastatic dissemination is mainly dependent upon the interactions between tumor and the surrounding microenvironment. Tumor microenvironment (TME) such as extracellular matrix, macrophages, fibroblasts, stem cells and endothelial cells can orchestrate events critical to tumor evolution toward metastasis. GJ serves as an important communication between tumor cells and stromal cells. Increased GJs coupling blocks metastatic potential in some cancer animal models such as breast cancer and melanoma. Besides, epithelial-to-mesenchymal transition (EMT) is also a crucial step in the metastatic process and there are signs that GJs contribute to cell adhesion and migration (the pathological feature of EMT) in breast cancer. Therefore, we propose that GJ serves as an intercellular glue to suppress EMT and cancer metastasis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer metastasis; Connexin; Epithelial–mesenchymal transition; Gap junction; Tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 27490999     DOI: 10.1016/j.canlet.2016.07.037

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  In Silico Approaches In Carcinogenicity Hazard Assessment: Current Status and Future Needs.

Authors:  Raymond R Tice; Arianna Bassan; Alexander Amberg; Lennart T Anger; Marc A Beal; Phillip Bellion; Romualdo Benigni; Jeffrey Birmingham; Alessandro Brigo; Frank Bringezu; Lidia Ceriani; Ian Crooks; Kevin Cross; Rosalie Elespuru; David M Faulkner; Marie C Fortin; Paul Fowler; Markus Frericks; Helga H J Gerets; Gloria D Jahnke; David R Jones; Naomi L Kruhlak; Elena Lo Piparo; Juan Lopez-Belmonte; Amarjit Luniwal; Alice Luu; Federica Madia; Serena Manganelli; Balasubramanian Manickam; Jordi Mestres; Amy L Mihalchik-Burhans; Louise Neilson; Arun Pandiri; Manuela Pavan; Cynthia V Rider; John P Rooney; Alejandra Trejo-Martin; Karen H Watanabe-Sailor; Angela T White; David Woolley; Glenn J Myatt
Journal:  Comput Toxicol       Date:  2021-09-23

2.  Oridonin inhibits migration, invasion, adhesion and TGF-β1-induced epithelial-mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK-3β signaling pathway.

Authors:  Chun-Yu Li; Qi Wang; Shen Shen; Xiao-Lu Wei; Guo-Xia Li
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

3.  Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma.

Authors:  Yan Yang; Na Zhang; Jian Zhu; Xiao-Ting Hong; Hao Liu; Yu-Rong Ou; Fang Su; Rui Wang; Yu-Mei Li; Qiong Wu
Journal:  Int J Oncol       Date:  2017-05-08       Impact factor: 5.650

4.  SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.

Authors:  Xianglin Hao; Fei Han; Bangjin Ma; Ning Zhang; Hongqiang Chen; Xiao Jiang; Li Yin; Wenbin Liu; Lin Ao; Jia Cao; Jinyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2018-05-31

5.  BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.

Authors:  Shidong Wang; Tingting Ren; Guangjun Jiao; Yi Huang; Xing Bao; Fan Zhang; Kuisheng Liu; Bingxin Zheng; Kunkun Sun; Wei Guo
Journal:  Oncotarget       Date:  2017-04-24

Review 6.  FOXF2 acts as a crucial molecule in tumours and embryonic development.

Authors:  Weihan He; Yuanbo Kang; Wei Zhu; Bolun Zhou; Xingjun Jiang; Caiping Ren; Weihua Guo
Journal:  Cell Death Dis       Date:  2020-06-05       Impact factor: 8.469

7.  Saikosaponin-d Inhibits the Hepatoma Cells and Enhances Chemosensitivity Through SENP5-Dependent Inhibition of Gli1 SUMOylation Under Hypoxia.

Authors:  Chun-Yan Zhang; Zhong-Min Jiang; Xiao-Fang Ma; Yue Li; Xiao-Zhi Liu; Li-Li Li; Wen-Han Wu; Tao Wang
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

8.  Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways.

Authors:  Yan Wu; Qin Cai; Wei Li; Zhensheng Cai; Ying Liu; Hongfan Li; Ji Pang; Yongchang Chen
Journal:  Biosci Rep       Date:  2019-08-13       Impact factor: 3.840

9.  Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting β-Tubulin in Triple-Negative Breast Cancer.

Authors:  Yun Fu; Xiaoyin Sun; Zhangyuan Gu; Zhigang Zhuang
Journal:  Onco Targets Ther       Date:  2020-06-10       Impact factor: 4.147

10.  Ouabain Enhances Gap Junctional Intercellular Communication by Inducing Paracrine Secretion of Prostaglandin E2.

Authors:  Alejandro Ogazon Del Toro; Lidia Jimenez; Mauricio Serrano Rubi; Marcelino Cereijido; Arturo Ponce
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.